Ultraflor Floor Tile (Congoleum Corporation, 1981–1983)

Congoleum Corporation’s Ultraflor floor tile was a resilient flooring product manufactured during a narrow production window from 1981 to 1983. Litigation records document that this product contained chrysotile asbestos as a component of its composition. Although the asbestos era in floor tile manufacturing was winding down by the early 1980s, Ultraflor represents one of the later-period products in which chrysotile was still incorporated into commercial and industrial flooring materials before stricter regulatory enforcement and industry reformulation removed asbestos from most resilient flooring lines.

Product Description

Ultraflor was a resilient floor tile manufactured by Congoleum Corporation, a company with a long history in the floor covering industry dating back to the early twentieth century. Congoleum produced a wide range of vinyl and vinyl-composition flooring products for residential, commercial, and industrial settings throughout much of the twentieth century. Ultraflor was positioned within Congoleum’s industrial and commercial product lines, reflecting the company’s reach beyond consumer markets into heavy-use flooring applications.

Resilient floor tiles of this era were typically produced in standard square formats designed for installation across large floor areas in warehouses, factories, commercial buildings, and institutional facilities. The tiles were engineered for durability under high foot traffic and industrial conditions, properties that made them attractive to facilities managers and contractors working in demanding environments. Ultraflor’s production dates of 1981 to 1983 place it squarely in a transitional period for the flooring industry, during which some manufacturers continued to use asbestos-containing formulations even as regulatory and liability pressures were mounting.

Congoleum Corporation has been the subject of extensive asbestos litigation related to its flooring product lines, and the company eventually filed for bankruptcy protection in part due to the volume of asbestos-related claims associated with its products manufactured over several decades.

Asbestos Content

Litigation records document that Ultraflor floor tiles contained chrysotile asbestos within their composition. Chrysotile, also known as white asbestos, is a serpentine form of asbestos that was by far the most widely used variety in American manufacturing throughout the twentieth century. It was incorporated into vinyl and vinyl-composition floor tiles for several practical reasons: chrysotile fibers added tensile strength and dimensional stability to the tile matrix, improved resistance to cracking and wear, and helped tiles maintain their shape and integrity under thermal and mechanical stress.

In resilient floor tile manufacturing, chrysotile asbestos was typically blended into a matrix of vinyl resins, plasticizers, fillers, and pigments. The resulting composite material was then pressed into tile form, cut to standard dimensions, and finished for distribution. During the manufacturing process, asbestos fibers were bound within the tile matrix, but the integrity of that binding could be compromised during cutting, grinding, installation, and especially during removal or renovation activities.

The U.S. Environmental Protection Agency’s Asbestos Hazard Emergency Response Act (AHERA) and related federal regulations recognize vinyl-asbestos floor tiles as a category of asbestos-containing material (ACM) requiring specific handling and abatement procedures. OSHA’s asbestos standards similarly identify floor tile disturbance as a regulated activity when tiles are confirmed or presumed to contain asbestos. Tiles manufactured during the period when Ultraflor was produced are generally treated as presumed asbestos-containing materials (PACM) under applicable federal guidelines until tested and confirmed otherwise.

How Workers Were Exposed

The population of workers most directly associated with exposure to Ultraflor tiles were industrial workers generally — those employed in settings where the tile was installed, maintained, disturbed, or removed. Litigation records document that workers in industrial and commercial environments encountered conditions that could release chrysotile fibers from Ultraflor and similar floor tile products.

Asbestos fiber release from floor tiles was most likely to occur during activities that physically disturbed the tile material. Installation work involving cutting, scoring, or trimming tiles to fit irregular floor areas generated dust that plaintiffs alleged contained respirable chrysotile fibers. Similarly, removal and renovation activities — during which old tiles were broken up, scraped from subfloors, or ground down — could release significantly higher concentrations of airborne asbestos fibers, particularly when power tools were used or when tiles were removed dry rather than with wet suppression methods.

Workers in industrial facilities where Ultraflor was installed over a period of years could also have experienced secondary or bystander exposure as floor tiles became worn, chipped, or damaged during normal operations. Industrial environments subject to heavy equipment traffic, forklift operation, or abrasive use could degrade tile surfaces over time, potentially releasing fibers into the workplace atmosphere. Maintenance workers performing floor repairs, janitors cleaning damaged tile areas, and tradespeople working in proximity to floor tile abatement activities were among those who plaintiffs alleged faced meaningful exposure risk.

It is well established in occupational health literature that chrysotile asbestos inhalation is associated with serious diseases including mesothelioma, asbestosis, and lung cancer. The latency period for asbestos-related diseases is typically measured in decades, meaning that workers exposed to Ultraflor tiles during their 1981 to 1983 production window and through the subsequent years of in-service use may be presenting with related diagnoses today.

Documented Trust Fund / Legal Options

Ultraflor is a Tier 2 — Litigated product. There is no established asbestos bankruptcy trust fund specifically associated with Congoleum Corporation’s Ultraflor floor tile through which claims can currently be filed using a standard trust claim process. Legal remedies for individuals injured by exposure to this product are pursued through civil litigation in the tort system.

Litigation records document that Congoleum Corporation has faced substantial asbestos-related legal action connected to its flooring products. Plaintiffs alleged that the company knew or should have known of the hazards posed by asbestos-containing products and failed to adequately warn workers and end users of those risks. Cases involving Congoleum flooring products have been filed in jurisdictions across the United States, with claims typically centered on diagnoses of mesothelioma, lung cancer, and asbestosis attributed to occupational exposure.

Individuals who were employed in industrial settings where Ultraflor was installed, maintained, or removed — and who have received an asbestos-related disease diagnosis — may have grounds to pursue civil claims. Legal counsel specializing in asbestos litigation can evaluate the specific circumstances of exposure, the applicable statute of limitations in the relevant jurisdiction, and the potential defendants beyond the primary manufacturer, including distributors, installers, and premises owners who may share liability.

Workers or surviving family members seeking to understand their legal options should consult with an asbestos litigation attorney as early as possible following diagnosis, as statutes of limitations vary by state and begin running from the date of diagnosis or discovery of the asbestos-related condition.

This article is provided for informational and reference purposes only and does not constitute legal advice. Individuals with potential asbestos exposure claims should consult qualified legal counsel.